Institute of Tropical Medicine Antwerp
Foundation of Public Utility

Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop

DSpace/Manakin Repository

Show simple item record Mühlberger, N. en_US Jelinek, T. en_US Gascon, J. en_US Probst, M. en_US Zoller, T. en_US Schunk, M. en_US Beran, J. en_US Gjorup, I. en_US Behrens, R. H. en_US Clerinx, J. en_US Björkmann, A. en_US McWhinney, P. en_US Matteelli, A. en_US Lopez-Velez, R. en_US Bisoffi, Z. en_US Hellgren, U. en_US Puente, S. en_US Schmid, M. L. en_US Myrvang, B. en_US Holthoff-Stich, M. L. en_US Laferl, H. en_US Hatz, C. en_US Kollaritsch, H. en_US Kapaun, A. en_US Knobloch, J. en_US Iversen, J. en_US Kotlowski, A. en_US Malvy, D. J. M. en_US Kern, P. en_US Fry, G. en_US Siikamaki, H. en_US Schulze, M. H. en_US Soula, G. en_US Paul, M. en_US Gómez i Prat, J. en_US Lehmann, V. en_US Bouchaud, O. en_US da Cunha, S. en_US Atouguia, J. en_US Boecken, G. en_US 2007-12-06T14:38:52Z 2007-12-06T14:38:52Z 2004 en_US
dc.identifier.issn 1475-2875 en_US
dc.identifier.other ITG-C10A en_US
dc.identifier.other CLINIC en_US
dc.identifier.other U-TROPIC en_US
dc.identifier.other JIF en_US
dc.identifier.other ELECTRONIC en_US
dc.identifier.other DOI en_US
dc.identifier.other FTA en_US
dc.identifier.other ABSTRACT en_US
dc.description.abstract BACKGROUND: Plasmodium vivax is the second most common species among malaria patients diagnosed in Europe, but epidemiological and clinical data on imported P. vivax malaria are limited. The TropNetEurop surveillance network has monitored the importation of vivax malaria into Europe since 1999. OBJECTIVES: To present epidemiological and clinical data on imported P. vivax malaria collected at European level. MATERIAL AND METHODS: Data of primary cases of P. vivax malaria reported between January 1999 and September 2003 were analysed, focusing on disease frequency, patient characteristics, place of infection, course of disease, treatment and differences between network-member countries. RESULTS: Within the surveillance period 4,801 cases of imported malaria were reported. 618 (12.9%) were attributed to P. vivax. European travellers and immigrants were the largest patient groups, but their proportion varied among the reporting countries. The main regions of infection in descending order were the Indian subcontinent, Indonesia, South America and Western and Eastern Africa, as a group accounting for more than 60% of the cases. Regular use of malaria chemoprophylaxis was reported by 118 patients. With 86 (inter-quartile range 41-158) versus 31 days (inter-quartile range 4-133) the median symptom onset was significantly delayed in patients with chemoprophylaxis (p < 0.0001). Common complaints were fever, headache, fatigue, and musculo-skeletal symptoms. All patients survived and severe clinical complications were rare. Hospitalization was provided for 60% and primaquine treatment administered to 83.8% of the patients, but frequencies varied strongly among reporting countries. CONCLUSIONS: TropNetEurop data can contribute to the harmonization of European treatment policies. en_US
dc.language English en_US
dc.publisher BioMed Central en_US
dc.subject Travel medicine en_US
dc.subject Imported diseases en_US
dc.subject Surveillance data en_US
dc.subject Protozoal diseases en_US
dc.subject Malaria en_US
dc.subject Plasmodium vivax en_US
dc.subject Europe en_US
dc.title Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop en_US
dc.type Article-E en_US
dc.citation.issue 5 en_US
dc.citation.jtitle Malaria Journal en_US
dc.citation.volume 3 en_US
dc.citation.pages 7 en_US London en_US
dc.citation.jabbreviation Malaria J en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record